Showing results (31-40 of 330) with videos related to

Sort By:
Pageof 33
Kidney International. Supplement|April 16, 2003
Cardiovascular risk in patients with mild renal insufficiencyJohannes F E Mann, Hertzel C Gerstein, Ioana Dulau-Florea, et al.
Diabetes Research and Clinical Practice|February 19, 2002
The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas--a randomized trialHertzel C Gerstein, Kevin E Thorpe, D Wayne Taylor, et al.
Diabetes Care|December 17, 2009
Effect of Rosiglitazone and Ramipril on {beta}-cell function in people with impaired glucose tolerance or impaired fasting glucose: the DREAM trialAnthony J Hanley, Bernard Zinman, Patrick Sheridan, et al.
The Lancet. Diabetes & Endocrinology|March 5, 2018
Do sulphonylureas still have a place in clinical practice?Kamlesh Khunti, Sudesna Chatterjee, Hertzel C Gerstein, et al.
Diabetes Care|November 15, 2018
Hypoglycemia and Incident Cognitive Dysfunction: A Post Hoc Analysis From the ORIGIN TrialTali Cukierman-Yaffe, Jackie Bosch, Hyejung Jung, et al.
Diabetes Care|May 21, 2010
The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysisDiana Sherifali, Kara Nerenberg, Eleanor Pullenayegum, et al.
American Heart Journal|July 11, 2026
Interpreting apparent differences among the major colchicine trials for cardiovascular prevention: a descriptive compatibility analysisThomas C Scheier, Hertzel C Gerstein, Arend Mosterd, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 20, 2004
Cardiovascular risk in patients with early renal insufficiency: implications for the use of ACE inhibitorsJohannes F E Mann, Hertzel C Gerstein, Janice Pogue, et al.
The Canadian Journal of Clinical Pharmacology = Journal Canadien De Pharmacologie Clinique|November 15, 2007
"I take what I think works for me": a qualitative study to explore patient perception of diabetes treatment benefits and risksKalpana M Nair, Mitchel A H Levine, Lynne H Lohfeld, et al.
The Journal of Clinical Endocrinology and Metabolism|April 4, 2017
Validation of the ORIGIN Cardiovascular Biomarker Panel and the Value of Adding Troponin I in Dysglycemic PeopleHertzel C Gerstein, Guillaume Paré, Matthew J McQueen, et al.
Pageof 33